Grimm Christoph

21PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsMedical biochemistry - amino acids and metabolitesCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Nov 26, 2025
Novel Treatment Concepts for Cervical Cancer-Moving Towards Personalized Therapy.

Melina Danisch, Magdalena Postl, Thomas Bartl

|May 12, 2025
Oncologic outcome of metachronous oligometastatic recurrence in advanced cervical cancer patients after primary radio-chemotherapy.

Thomas Bartl, Tim Dorittke, Cristina Ciocsirescu

|Mar 13, 2025
ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer.

Valentina Glueck, Christoph Grimm, Magdalena Postl

|Oct 24, 2024
Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer.

Alejandro Perez-Fidalgo, Barbara Schmalfeldt, Angela George

|Oct 16, 2024
Novel Targeted Agents in Advanced and Recurrent Low-Grade Serous Ovarian Cancer: A Silver Lining in the Therapy of a Chemoresistant Disease?

Arina Onoprienko, Thomas Bartl, Christoph Grimm

|Jun 27, 2024
Oncologic and Obstetric Outcomes Following Radical Abdominal Trachelectomy in Non-Low-Risk Early-Stage Cervical Cancers: A 10-Year Austrian Single-Center Experience.

Melina Danisch, Marlene Kranawetter, Thomas Bartl

Pageof 4

Frequent Collaborators

10 joint publications

Thomas Bartl

6 joint publications

Stephan Polterauer

5 joint publications

Leonhard Müllauer

3 joint publications

Stefanie Aust